Published in

Taylor and Francis Group, Expert Opinion on Drug Safety, p. 1-8, 2022

DOI: 10.1080/14740338.2022.2110237

Links

Tools

Export citation

Search in Google Scholar

Analysis and visualization of the course and burden over time of adverse drug reactions (ADRs) attributed to TNFα-inhibitors in patients with inflammatory rheumatic diseases (IRDs)

Journal article published in 2022 by Merel de Boer ORCID, Helen R. Gosselt, Jurriaan Jansen, Martijn B. A. van Doorn ORCID, Frank Hoentjen, Michael T. Nurmohamed ORCID, Phyllis I. Spuls, Sander W. Tas, Harald E. Vonkeman ORCID, Naomi T. Jessurun ORCID
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO